Managed Healthcare Executive September 12, 2023
Matthew Majewski and Rhett Johnson of Charles River Associates explain some of the provisions of the Inflation Reduction Act and what they mean for life sciences companies.
First of three parts: Expanding patient access to healthcare
The Inflation Reduction Act (IRA) of 2022, signed into law last August, contains some of the most significant changes in healthcare regulation since the introduction of the Medicare Modernization Act of 2003. There are many healthcare-related policy changes contained in the IRA, which can be categorized into three major sections: expansion of patient access to affordable insurance, adjustments to medication pricing and reimbursement and reforms to patient cost-sharing
There are at least three important changes within the IRA impacting patient access to health insurance.
...Today's Sponsors
Today's Sponsor